GRANADILLO PEDRO P 4

Accession 0001127602-18-028076

CIK 0000313143other

Filed

Sep 18, 8:00 PM ET

Accepted

Sep 19, 5:00 PM ET

Size

23.0 KB

Accession

0001127602-18-028076

Form 4

Period: 2018-09-17

Director

Transactions

Exercise/Conversion
Common Stock
2018-09-17$45.45/sh+6,573$298,743→ 48,128 total
Sale
Common Stock
2018-09-17$110.11/sh−3,696$406,967→ 53,283 total
Sale
Common Stock
2018-09-17$113.16/sh−11,812$1,336,646→ 28,288 total
Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2018-09-17−6,573→ 0 total
Exercise: $45.45From: 2014-07-24Exp: 2020-07-24→ Common Stock (6,573 underlying)
Exercise/Conversion
Common Stock
2018-09-17$35.50/sh+10,353$367,532→ 58,481 total
Sale
Common Stock
2018-09-17$108.92/sh−1,502$163,598→ 56,979 total
Sale
Common Stock
2018-09-17$111.33/sh−13,183$1,467,663→ 40,100 total
Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2018-09-17−8,196→ 0 total
Exercise: $36.37From: 2013-07-27Exp: 2019-07-27→ Common Stock (8,196 underlying)
Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2018-09-17−10,353→ 0 total
Exercise: $35.50From: 2015-07-23Exp: 2021-07-23→ Common Stock (10,353 underlying)
Sale
Common Stock
2018-09-17$114.16/sh−631$72,035→ 27,657 total
Exercise/Conversion
Common Stock
2018-09-17$36.37/sh+8,196$298,089→ 41,555 total

Footnotes (8)

[F1]Transaction pursuant to an existing 10b5-1 trading plan.
[F2]This number includes unvested restricted stock units previously reported.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.61 to $109.33, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (7) to this Form 4.
[F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.79 to $110.55, inclusive.
[F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.92 to 111.88, inclusive.
[F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.51 to $113.35, inclusive.
[F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114 to $114.44, inclusive.
[F8]Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.

Documents

1 file

HAEMONETICS CORP

CIK 0000313143

Entity typeother